These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18518931)

  • 1. Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis.
    Palermo A; Mulè G; Guarneri M; Arsena R; Riccobene R; Lorito MC; Vaccaro F; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Dec; 13(6):467-71. PubMed ID: 18518931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease.
    Cottone S; Palermo A; Arsena R; Riccobene R; Guarneri M; Mulè G; Tornese F; Altieri C; Vaccaro F; Previti A; Cerasola G
    J Nephrol; 2010; 23(1):62-9. PubMed ID: 20091488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function.
    Kanbay M; Isik B; Akcay A; Ozkara A; Karakurt F; Turgut F; Alkan R; Uz E; Bavbek N; Yigitoglu R; Covic A
    Am J Nephrol; 2007; 27(5):516-21. PubMed ID: 17703091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.
    Felsenfeld AJ; Rodríguez M; Aguilera-Tejero E
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1283-305. PubMed ID: 17942777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients.
    Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI
    Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of parathormone on arterial blood pressure in patients on hemodialysis].
    Kostić S; Veljković S; Cekić S; Nesić M; Cukuranović R; Koradjević G; Radenković S; Velicković D; Raicević R; Radenković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():115-6. PubMed ID: 9102868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
    Nasri H; Kheiri S
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients.
    Morrone LF; Mazzaferro S; Russo D; Aucella F; Cozzolino M; Facchini MG; Galfrè A; Malberti F; Mereu MC; Nordio M; Pertosa G; Santoro D;
    Nephrol Dial Transplant; 2009 Sep; 24(9):2859-65. PubMed ID: 19369685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism.
    Abdul Gafor AH; Saidin R; Loo CY; Mohd R; Zainudin S; Shah SA; Norella KC
    Nephrology (Carlton); 2009 Aug; 14(5):488-92. PubMed ID: 19298641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
    Hwang JC; Chen CA; Wang CT; Chen HC
    Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The discrepancy on measurement of parathyroid hormone in blood under the condition of diseases in hemodialysis patients with renal insufficiency and elderly osteoporotic patients].
    Ueyoshi A; Kiura Y; Ota K; Okamoto Y
    Ryumachi; 1988 Oct; 28(5):324-33. PubMed ID: 3227463
    [No Abstract]   [Full Text] [Related]  

  • 16. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH; Johnson ES; Thorp ML; Yang X
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
    El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
    Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
    Tokmak F; Quack I; Schieren G; Sellin L; Rattensperger D; Holland-Letz T; Weiner SM; Rump LC
    Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.